Writing
Tagged “drug-development”
2 pieces tagged “drug-development”, across articles and the blog.
-
The regulatory door just opened for new approach methodologies
FDA’s draft guidance on non-animal methods runs on two principles: context of use and weight of evidence. Together they tell you exactly where a predictive model is allowed to sit.
-
A thinking tool, not a decision tool
Virtual cell models trained on causal perturbation data are a real scientific step up. Looked at from a regulatory perspective, they still sit upstream of anything FDA would accept as evidence.